(@mbl2018)

AoU Research Priorities Use Cases

How do mindsets about illness & treatment affect biomarkers of inflammation & treatment outcomes in patients w/ chronic illness?

Half of all Americans are diagnosed with one or more chronic illnesses, like heart disease and cancer. Mindsets about these illnesses may have a profound impact on the diagnosis, progression, and treatment of these illnesses. This study aims to: (1) understand the distribution of mindsets held by a diverse group of both healthy and chronically ill Americans, and (2) identify relationships between these mindsets, biomarkers... more »

Voting

0 votes
Ideate
(@judithjames808)

AoU Research Priorities Use Cases

Identification of at-risk individuals for autoimmune disease prevention and discovery of natural history

Autoimmune diseases afflict nearly 1 in 12 Americans and many more have autoantibodies but no evidence of clinical disease. Recent work has identified biomarkers or clinical symptoms which associate with subsequent developing development of systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) and NIH-funded prevention trials are underway. AoU provides a unique opportunity to identify at risk individuals through... more »

Voting

2 votes
Ideate
(@judithjames808)

AoU Research Priorities Use Cases

What environmental and genetic factors influence the development of osteoarthritis?

Osteoarthritis (OA) is the most common cause of disability in the United States, and there are no available biomarkers or disease-modifying therapies for OA. Currently, we are unable to identify rapidly progressive OA patients at diagnosis. All of Us offers a unique opportunity to obtain clinical data and biospecimens, along with diet and exercise information, which associate with rapidly progressive OA to help foster... more »

Voting

2 votes
Ideate
(@judithjames808)

AoU Research Priorities Use Cases

What environmental and genetic factors influence the development of osteoarthritis?

Osteoarthritis (OA) is the most common cause of disability in the United States, and there are no available biomarkers or disease-modifying therapies for OA. Currently, we are unable to identify rapidly progressive OA patients at diagnosis. All of Us offers a unique opportunity to obtain clinical data and biospecimens, along with diet and exercise information, which associate with rapidly progressive OA to help foster... more »

Voting

2 votes
Ideate
(@lisa.signorello)

AoU Research Priorities Use Cases

To develop or optimize a non-invasive BIOMARKER that can be used to measure the experience of stress in children and adults.

The impact of psychosocial stress on child and adult health risk is increasingly appreciated. The measurement of this exposure is currently poor, and All of Us has the opportunity to develop or refine biomarkers that could help push this field of research forward in a valid way for the future. Such biomarkers could be a part of individual studies of stress and disease, and could also be used as a gold standard to develop... more »

Voting

3 votes
Ideate
(@brodyj)

AoU Research Priorities Use Cases

What are the best ways to report back to participants on biomarkers for environmental chemicals?

All of Us has committed to reporting back to participants on their biomarkers. The study can advance methods for reporting on environmental chemicals in the context of genetic data and health by studying the experiences of All of Us participants, including how they view and use their reports, their cognitive and emotional responses, and other outcomes.

Voting

5 votes
Ideate
(@brodyj)

AoU Research Priorities Use Cases

Does exposure to endocrine disrupting compounds (EDCs) influence the effectiveness of treatments for hormonal cancers?

EDCs are widespread in consumer products, air, and drinking water. Cancer treatments (such as tamoxifen and aromatase inhibitors for breast cancers) depend on altering the body's hormone levels. All of Us could evaluate whether EDCs interfere with cancer treatments. This study would involve assessing EDC exposure in patients during treatment and evaluating hormonal outcomes and disease progression outcomes.

Voting

2 votes
Ideate
(@brodyj)

AoU Research Priorities Use Cases

Does exposure to endocrine disrupting compounds (EDCs) influence the effectiveness of treatments for hormonal cancers?

EDCs are widespread in consumer products, air, and drinking water. Cancer treatments (such as tamoxifen and aromatase inhibitors for breast cancers) depend on altering the body's hormone levels. All of Us could evaluate whether EDCs interfere with cancer treatments. This study would involve assessing EDC exposure in patients during treatment and evaluating hormonal outcomes and disease progression outcomes.

Voting

2 votes
Ideate
(@pjb000)

AoU Research Priorities Use Cases

Will the clinical use of predictive glycation and oxidation biomarkers improve diabetes care and prevent long-term complications

Since diabetic complications occur in those that show more glycative and oxidative stress, we have validated their predictive power in ground-breaking outcome trials to create diagnostic blood tests for clinical use. To study the clinical efficacy and utility of these tests we will identify those at high risk (HR) before DKD and CVD are apparent. Primary endpoints are achievement of rigorous glycemic and proposed treatment... more »

Voting

11 votes
Ideate
(@renaissance)

AoU Research Priorities Use Cases

How reliably do epigenetic aging clocks predict disease onset and mortality? Can they be slowed or reversed?

An annual blood test with analysis of methylation sites from key epigenetic aging clocks (e.g. Horvath). Epigenetic aging clocks have already been shown to reliably predict age, time-to-death, all cause mortality, cog. function, immune function, CV disease, cancer, and more. They may also become a key tool to demonstrate the reversibility of disease risk through dietary and therapeutic regimens, as epigenetic states are... more »

Voting

35 votes
Ideate
(@renaissance)

AoU Research Priorities Use Cases

How reliably do epigenetic aging clocks predict disease onset and mortality? Can they be slowed or reversed?

An annual blood test with analysis of methylation sites from key epigenetic aging clocks (e.g. Horvath). Epigenetic aging clocks have already been shown to reliably predict age, time-to-death, all cause mortality, cog. function, immune function, CV disease, cancer, and more. They may also become a key tool to demonstrate the reversibility of disease risk through dietary and therapeutic regimens, as epigenetic states are... more »

Voting

35 votes
Ideate
(@visarb)

AoU Research Priorities Use Cases

Can measures of speech and language be pre-clinical predictors of neurological disease?

Complex brain networks are responsible for translating thoughts and ideas into sequences of movements that produce the sounds of speech. Any disturbance in these networks can lead to changes in how we speak and what we say. Evidence shows that subtle changes in speech are early harbingers of neurological disease. We propose to use the AoU platform to validate this hypothesis on a large scale and to develop AI tools for... more »

Voting

2 votes
Ideate
(@petercastellano6)

AoU Research Priorities Use Cases

How Do We Define Health and Then How do we measure it?

What does health mean these days? Health has 2 components: (1) mental and emotional happiness, which is harder to measure, and (2) biochemical health, which is measureable. Goals: Define Health and then Define measurements (markers) of Health Methods: Set forth the measurements of health, monitor and collect the dietary and biomarker data of people overtime, and record good/bad outcomes and then related back to dietary... more »

Voting

3 votes
Ideate